A Randomized Controlled Trial for Combined Patching and Atropine vs. Patching in the Treatment of Children with Severe Amblyopia

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800018663

Enrollment

Unknown

Registered

2018-10-02

Start date

2018-11-01

Completion date

Unknown

Last updated

2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

amblyopia

Interventions

treatment group:patch+atropine

control group:patch

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Children with monocular anisometropic amblyopia and visual acuity worse than 0.2; 2. Aged 3 to 12 years old.

Exclusion criteria

Exclusion criteria: 1. Ocular organic lesion 2. Developmental retardation 3. History of amblyopia treatment

Design outcomes

Primary

Measure	Time frame
visual acuity;	—

Secondary

Measure	Time frame
binocular vision;fixation;	—

Countries

China

Contacts

Public ContactHong Liu

Eye & ENT Hospital of Fudan University

liuhongzef@263.net+86 18917785745

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026